{
  "name": "Mark Skinner",
  "first_name": "Mark",
  "last_name": "Skinner",
  "middle_names": "",
  "title": "Assistant Clinical Professor (Adjunct), Health Research Methods, Evidence, and Impact",
  "photo_url": "https://experts.mcmaster.ca/images/placeholders/person.thumbnail.jpg",
  "email": "skinnm5@mcmaster.ca",
  "websites": [],
  "linkedin": "",
  "twitter": "",
  "websites_json": "[]",
  "primary_website": "",
  "overview": "",
  "affiliations_json": "[{\"organizations\": \"Faculty of Health Sciences > McMaster University\"}, {\"position\": \"Assistant Clinical Professor (Adjunct)\", \"organizations\": \"Health Research Methods, Evidence, and Impact > Faculty of Health Sciences\"}]",
  "all_affiliations": "Faculty of Health Sciences > McMaster University ; Assistant Clinical Professor (Adjunct), Health Research Methods, Evidence, and Impact > Faculty of Health Sciences",
  "all_organizations": "Faculty of Health Sciences > McMaster University ; Health Research Methods, Evidence, and Impact > Faculty of Health Sciences",
  "primary_affiliation": "Faculty of Health Sciences > McMaster University",
  "primary_position": "",
  "research_areas": "",
  "research_areas_json": "[]",
  "education_json": "[]",
  "all_degrees": "",
  "all_degrees_only": "",
  "all_institutions": "",
  "highest_degree": "",
  "degree_institution": "",
  "total_publications": 124,
  "journal_articles_count": 72,
  "book_chapters_count": 6,
  "conference_papers_count": 43,
  "recent_publications_count": 59,
  "publications_json": "{\"journal_articles\": [{\"title\": \"Recommending defunct therapies is a safety risk for hemophilia.\", \"url\": \"https://experts.mcmaster.ca/display/publication3540487\", \"journal\": \"Blood Transfusion\", \"year\": \"2025\", \"doi\": \"10.2450/BloodTransfus.982\"}, {\"title\": \"Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY Studies.\", \"url\": \"https://experts.mcmaster.ca/display/publication3505266\", \"journal\": \"Haemophilia\", \"year\": \"2025\", \"doi\": \"10.1111/hae.15134\"}, {\"title\": \"Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3494611\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15136\"}, {\"title\": \"International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.\", \"url\": \"https://experts.mcmaster.ca/display/publication3494222\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15135\"}, {\"title\": \"A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiative.\", \"url\": \"https://experts.mcmaster.ca/display/publication3492767\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15122\"}, {\"title\": \"Development of the World Federation of Hemophilia Shared Decision-Making Tool.\", \"url\": \"https://experts.mcmaster.ca/display/publication3477986\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15100\"}, {\"title\": \"Development of the coreHEM mental health patient-reported outcome measure - A novel mental health outlook measure for people with haemophilia.\", \"url\": \"https://experts.mcmaster.ca/display/publication3470094\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15085\"}, {\"title\": \"Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List\", \"url\": \"https://experts.mcmaster.ca/display/publication3460416\", \"journal\": \"The Lancet Haematology\", \"year\": \"2024\", \"doi\": \"10.1016/s2352-3026(24)00223-0\"}, {\"title\": \"Association of patient, treatment and disease characteristics with patient\\u2010reported outcomes: Results of the ECHO Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication3320502\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.14895\"}, {\"title\": \"Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1\", \"url\": \"https://experts.mcmaster.ca/display/publication3290241\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.jtha.2023.08.032\"}, {\"title\": \"Hemophilia gene therapy: first, do no harm\", \"url\": \"https://experts.mcmaster.ca/display/publication3259128\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.jtha.2023.06.016\"}, {\"title\": \"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science\", \"url\": \"https://experts.mcmaster.ca/display/publication2981108\", \"journal\": \"Expert Review of Hematology\", \"year\": \"2023\", \"doi\": \"10.1080/17474086.2023.2183836\"}, {\"title\": \"Data sharing to advance gene\\u2010targeted therapies in rare diseases\", \"url\": \"https://experts.mcmaster.ca/display/publication2658805\", \"journal\": \"American Journal of Medical Genetics - Seminars in Medical Genetics\", \"year\": \"2023\", \"doi\": \"10.1002/ajmg.c.32028\"}, {\"title\": \"Gene\\u2010targeted therapies: Towards equitable development, diagnosis, and access\", \"url\": \"https://experts.mcmaster.ca/display/publication2777362\", \"journal\": \"American Journal of Medical Genetics - Seminars in Medical Genetics\", \"year\": \"2023\", \"doi\": \"10.1002/ajmg.c.32032\"}, {\"title\": \"Humanistic burden of problem joints for children and adults with haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2658804\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14731\"}, {\"title\": \"Prophylaxis use of clotting factor replacement products in people with non\\u2010severe haemophilia: A review of the literature\", \"url\": \"https://experts.mcmaster.ca/display/publication2440132\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14676\"}, {\"title\": \"Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B\", \"url\": \"https://experts.mcmaster.ca/display/publication2178281\", \"journal\": \"Journal of Medical Economics\", \"year\": \"2022\", \"doi\": \"10.1080/13696998.2022.2049552\"}, {\"title\": \"Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years\", \"url\": \"https://experts.mcmaster.ca/display/publication2431417\", \"journal\": \"The Lancet Haematology\", \"year\": \"2022\", \"doi\": \"10.1016/s2352-3026(22)00209-5\"}, {\"title\": \"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2172480\", \"journal\": \"JMIR Human Factors\", \"year\": \"2022\", \"doi\": \"10.2196/30797\"}, {\"title\": \"A preliminary application of a haemophilia value framework to emerging therapies in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2178284\", \"journal\": \"Haemophilia\", \"year\": \"2022\", \"doi\": \"10.1111/hae.14511\"}, {\"title\": \"The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making\", \"url\": \"https://experts.mcmaster.ca/display/publication2274074\", \"journal\": \"Patient Preference and Adherence\", \"year\": \"2022\", \"doi\": \"10.2147/ppa.s355627\"}, {\"title\": \"Eliminating Panglossian thinking in development of AAV therapeutics\", \"url\": \"https://experts.mcmaster.ca/display/publication2154110\", \"journal\": \"Molecular Therapy\", \"year\": \"2021\", \"doi\": \"10.1016/j.ymthe.2021.10.025\"}, {\"title\": \"Evaluation of the sexual health in people living with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2129783\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14410\"}, {\"title\": \"Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment\", \"url\": \"https://experts.mcmaster.ca/display/publication2049462\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14383\"}, {\"title\": \"The effect of emicizumab prophylaxis on long\\u2010term, self\\u2010reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies\", \"url\": \"https://experts.mcmaster.ca/display/publication1987173\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14363\"}, {\"title\": \"Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre\\u2019s readiness in United States and EU\", \"url\": \"https://experts.mcmaster.ca/display/publication1967597\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14309\"}, {\"title\": \"Vaccination against COVID\\u201019: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication1960659\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14271\"}, {\"title\": \"Patient\\u2010relevant health outcomes for hemophilia care: Development of an international standard outcomes set\", \"url\": \"https://experts.mcmaster.ca/display/publication1963914\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1002/rth2.12488\"}, {\"title\": \"Evidence of a disability paradox in patient\\u2010reported outcomes in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1959641\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14278\"}, {\"title\": \"Identified unmet needs and proposed solutions in mild\\u2010to\\u2010moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts\", \"url\": \"https://experts.mcmaster.ca/display/publication1958361\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14168\"}, {\"title\": \"Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication2142543\", \"journal\": \"Journal of Blood Medicine\", \"year\": \"2021\", \"doi\": \"10.2147/jbm.s325031\"}, {\"title\": \"Non\\u2010severe haemophilia: Is it benign? \\u2013 Insights from the PROBE study\", \"url\": \"https://experts.mcmaster.ca/display/publication1923964\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14105\"}, {\"title\": \"Personalising haemophilia management with shared decision making\", \"url\": \"https://experts.mcmaster.ca/display/publication3561871\", \"journal\": \"The Journal of Haemophilia Practice\", \"year\": \"2021\", \"doi\": \"10.17225/jhp00178\"}, {\"title\": \"The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication3561872\", \"journal\": \"The Journal of Haemophilia Practice\", \"year\": \"2021\", \"doi\": \"10.17225/jhp00176\"}, {\"title\": \"Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company\", \"url\": \"https://experts.mcmaster.ca/display/publication1936087\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14144\"}, {\"title\": \"Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication1937783\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1111/jth.15023\"}, {\"title\": \"Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?\", \"url\": \"https://experts.mcmaster.ca/display/publication1925854\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14131\"}, {\"title\": \"The role of telemedicine in the delivery of health care in the COVID\\u201019 pandemic\", \"url\": \"https://experts.mcmaster.ca/display/publication1894317\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14044\"}, {\"title\": \"The World Federation of Hemophilia Annual Global Survey 1999\\u20102018\", \"url\": \"https://experts.mcmaster.ca/display/publication1914356\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14012\"}, {\"title\": \"World Federation of Hemophilia Gene Therapy Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1910847\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14015\"}, {\"title\": \"Achieving the unimaginable: Health equity in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1679558\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.13862\"}, {\"title\": \"An international survey to inform priorities for new guidelines on von Willebrand disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1680493\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.13881\"}, {\"title\": \"Exploring regional variations in the cross\\u2010cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication1634148\", \"journal\": \"Haemophilia\", \"year\": \"2019\", \"doi\": \"10.1111/hae.13703\"}, {\"title\": \"Hemophilia trials in the twenty\\u2010first century: Defining patient important outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1639469\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1002/rth2.12195\"}, {\"title\": \"The 1stWFHGene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world\", \"url\": \"https://experts.mcmaster.ca/display/publication1751434\", \"journal\": \"Haemophilia\", \"year\": \"2019\", \"doi\": \"10.1111/hae.13673\"}, {\"title\": \"Test\\u2010retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains\", \"url\": \"https://experts.mcmaster.ca/display/publication1612046\", \"journal\": \"Haemophilia\", \"year\": \"2019\", \"doi\": \"10.1111/hae.13649\"}, {\"title\": \"The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1505309\", \"journal\": \"Pilot and Feasibility Studies\", \"year\": \"2018\", \"doi\": \"10.1186/s40814-018-0253-0\"}, {\"title\": \"Aging Through the Lens of Historical Time, Space, and Place\", \"url\": \"https://experts.mcmaster.ca/display/publication1728103\", \"journal\": \"The Gerontologist\", \"year\": \"2018\", \"doi\": \"10.1093/geront/gny070\"}, {\"title\": \"Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project\", \"url\": \"https://experts.mcmaster.ca/display/publication1534544\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13504\"}, {\"title\": \"Genotypes, phenotypes and whole genome sequence: Approaches from theMy Life Our Futurehaemophilia project\", \"url\": \"https://experts.mcmaster.ca/display/publication1635782\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13506\"}, {\"title\": \"Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies\", \"url\": \"https://experts.mcmaster.ca/display/publication1635783\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13313\"}, {\"title\": \"Risk\\u2010based decision making and ethical considerations in donor compensation for plasma\\u2010derived medicinal products\", \"url\": \"https://experts.mcmaster.ca/display/publication1635794\", \"journal\": \"Transfusion\", \"year\": \"2016\", \"doi\": \"10.1111/trf.13764\"}, {\"title\": \"Improving comprehensive care in the haemophilia community: building on theHEROStudy\", \"url\": \"https://experts.mcmaster.ca/display/publication1635784\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.12945\"}, {\"title\": \"NHF\\u2010McMaster Guideline on Care Models for Haemophilia Management\", \"url\": \"https://experts.mcmaster.ca/display/publication172779\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13008\"}, {\"title\": \"Assessments of outcome in haemophilia \\u2013 a patient perspective\", \"url\": \"https://experts.mcmaster.ca/display/publication1635785\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.12922\"}, {\"title\": \"The national haemophilia program standards, evaluation and oversight systems in the United States of America.\", \"url\": \"https://experts.mcmaster.ca/display/publication1635797\", \"journal\": \"Blood Transfusion\", \"year\": \"2014\", \"doi\": \"10.2450/2014.0019-14s\"}, {\"title\": \"World Federation of Hemophilia: 50\\u00a0years of advancing treatment for all\", \"url\": \"https://experts.mcmaster.ca/display/publication1635786\", \"journal\": \"Haemophilia\", \"year\": \"2013\", \"doi\": \"10.1111/hae.12200\"}, {\"title\": \"Factor VIII Products and Inhibitors in Severe Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication411185\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2013\", \"doi\": \"10.1056/nejmc1301995\"}, {\"title\": \"Factor VIII products and inhibitors in severe hemophilia A.\", \"url\": \"https://experts.mcmaster.ca/display/publication172957\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2013\", \"doi\": \"10.1056/NEJMc1301995\"}, {\"title\": \"Gene Therapy for Hemophilia: Addressing the Coming Challenges of Affordability and Accessibility\", \"url\": \"https://experts.mcmaster.ca/display/publication1635787\", \"journal\": \"Molecular Therapy\", \"year\": \"2013\", \"doi\": \"10.1038/mt.2012.272\"}, {\"title\": \"Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)\", \"url\": \"https://experts.mcmaster.ca/display/publication1635888\", \"journal\": \"American Heart Journal\", \"year\": \"2012\", \"doi\": \"10.1016/j.ahj.2012.04.015\"}, {\"title\": \"Haemophilia care \\u2013 past, present and future from a patient perspective\", \"url\": \"https://experts.mcmaster.ca/display/publication1635788\", \"journal\": \"Haemophilia\", \"year\": \"2012\", \"doi\": \"10.1111/j.1365-2516.2012.02892.x\"}, {\"title\": \"WFH: Closing the global gap \\u2013 achieving optimal care\", \"url\": \"https://experts.mcmaster.ca/display/publication1635802\", \"journal\": \"Haemophilia\", \"year\": \"2012\", \"doi\": \"10.1111/j.1365-2516.2012.02822.x\"}, {\"title\": \"Ensuring maximum outcomes and benefits in comprehensive care for bleeding disorders through surveillance and data collection\", \"url\": \"https://experts.mcmaster.ca/display/publication1635807\", \"journal\": \"Hematology\", \"year\": \"2012\", \"doi\": \"10.1179/102453312x13336169156573\"}, {\"title\": \"Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1751606\", \"journal\": \"Molecular Therapy\", \"year\": \"2011\", \"doi\": \"10.1038/mt.2011.203\"}, {\"title\": \"Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements\", \"url\": \"https://experts.mcmaster.ca/display/publication1635789\", \"journal\": \"British Journal of Haematology\", \"year\": \"2011\", \"doi\": \"10.1111/j.1365-2141.2011.08765.x\"}, {\"title\": \"Building our global family \\u2013 achieving treatment for all\", \"url\": \"https://experts.mcmaster.ca/display/publication1635790\", \"journal\": \"Haemophilia\", \"year\": \"2010\", \"doi\": \"10.1111/j.1365-2516.2010.02285.x\"}, {\"title\": \"Global data and haemophilia care trends: commentary\", \"url\": \"https://experts.mcmaster.ca/display/publication1635806\", \"journal\": \"Haemophilia\", \"year\": \"2010\", \"doi\": \"10.1111/j.1365-2516.2009.02177.x\"}, {\"title\": \"WFH \\u2013 the cornerstone of global development: 45\\u2003years of progress\", \"url\": \"https://experts.mcmaster.ca/display/publication1635791\", \"journal\": \"Haemophilia\", \"year\": \"2008\", \"doi\": \"10.1111/j.1365-2516.2008.01707.x\"}, {\"title\": \"Treatment for all: a vision for the future\", \"url\": \"https://experts.mcmaster.ca/display/publication1635792\", \"journal\": \"Haemophilia\", \"year\": \"2006\", \"doi\": \"10.1111/j.1365-2516.2006.01280.x\"}, {\"title\": \"More on: are randomized clinical trials the only truth? Not always\", \"url\": \"https://experts.mcmaster.ca/display/publication1635830\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2006\", \"doi\": \"10.1111/j.1538-7836.2006.01938.x\"}, {\"title\": \"What is a cure and how do we get there?\", \"url\": \"https://experts.mcmaster.ca/display/publication1635824\", \"journal\": \"Haemophilia\", \"year\": \"2004\", \"doi\": \"10.1111/j.1365-2516.2004.00999.x\"}], \"chapters\": [{\"title\": \"Geographical gerontology: Progress and possibilities\", \"url\": \"https://experts.mcmaster.ca/display/publication1728053\", \"year\": \"2017\", \"doi\": \"10.4324/9781315281216\"}, {\"title\": \"Space and place in geographical gerontology: Theoretical traditions, formations of hope\", \"url\": \"https://experts.mcmaster.ca/display/publication1728054\", \"year\": \"2017\", \"doi\": \"10.4324/9781315281216\"}, {\"title\": \"Ageing Resource Communities\", \"url\": \"https://experts.mcmaster.ca/display/publication1751634\", \"year\": \"2015\", \"doi\": \"10.4324/9781315728209\"}, {\"title\": \"Perspectives on rural voluntarism\", \"url\": \"https://experts.mcmaster.ca/display/publication1751640\", \"year\": \"2015\", \"doi\": \"10.4324/9781315728209\"}, {\"title\": \"Aging and Older People, Geography of\", \"url\": \"https://experts.mcmaster.ca/display/publication1728052\", \"year\": \"2015\", \"doi\": \"10.1016/b978-0-08-097086-8.72115-5\"}, {\"title\": \"Comprehensive care and delivery of care: the global perspective\", \"url\": \"https://experts.mcmaster.ca/display/publication3261927\", \"year\": \"2014\"}], \"conferences\": [{\"title\": \"Test\\u2013retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995654\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.14969\"}, {\"title\": \"Initial results of the impact of valoctocogene roxaparvovec on pain occurrence and interference: Insights from PROBE\", \"url\": \"https://experts.mcmaster.ca/display/publication3277051\", \"journal\": \"Haemophilia\", \"year\": \"2023\"}, {\"title\": \"A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA\", \"url\": \"https://experts.mcmaster.ca/display/publication2980744\", \"journal\": \"American Journal of Hematology\", \"year\": \"2023\"}, {\"title\": \"COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK\", \"url\": \"https://experts.mcmaster.ca/display/publication2981099\", \"journal\": \"American Journal of Hematology\", \"year\": \"2023\"}, {\"title\": \"NATIONAL ECONOMIC BURDEN OF ADULTS WITH SEVERE HEMOPHILIA A MANAGED WITH PROPHYLAXIS IN THE UNITED STATES\", \"url\": \"https://experts.mcmaster.ca/display/publication2981098\", \"journal\": \"American Journal of Hematology\", \"year\": \"2023\"}, {\"title\": \"A Novel Methodology for Building Longitudinal, PatientCentric Real World Datasets in Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication2429824\", \"journal\": \"Blood\", \"year\": \"2021\", \"doi\": \"10.1182/blood-2021-146160Get\"}, {\"title\": \"Relationship of EQ-5D Pain Domain and Bleeds - Insights from the PROBE Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2122576\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY\", \"url\": \"https://experts.mcmaster.ca/display/publication1962004\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"Examination and Validation of a Patient-Centric Joint Metric: \\\"Problem Joint\\\"; Empirical Evidence from the CHESS US Dataset\", \"url\": \"https://experts.mcmaster.ca/display/publication1979439\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood-2020-140950\"}, {\"title\": \"Developing a patient reported outcome measure to explore mental health outlook in people with Hemophilia: Development of a conceptual framework\", \"url\": \"https://experts.mcmaster.ca/display/publication1915794\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Education in people with Hemophilia - Insights from the PROBE Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1914746\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Impact of Pain on Physical Activity by Persons with Hemophilia (PwH) from the HemACTIVE Patient Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication1915792\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"International Standard Set of Health Outcomes that matter for people living with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1914745\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Quantifying the disability paradox in hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1915791\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Treatment adherence in people with hemophilia (PwH) who are restricted by pain: Findings from the HemACTIVE Patient Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication1915793\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY\", \"url\": \"https://experts.mcmaster.ca/display/publication1692273\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1639464\", \"journal\": \"Molecular Therapy\", \"year\": \"2019\"}, {\"title\": \"\\\"Problem Joint\\\" a more patient relevant definition for joint morbidity in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1628471\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Impact of acute and chronic pain on the EQ-5D: Insights from the PROBE study\", \"url\": \"https://experts.mcmaster.ca/display/publication1628468\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study\", \"url\": \"https://experts.mcmaster.ca/display/publication1628469\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Physical activity in persons with hemophilia (PwH) from France (FR), Italy (ITA), and United States (US) from the hemactive patient survey\", \"url\": \"https://experts.mcmaster.ca/display/publication1628467\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort\", \"url\": \"https://experts.mcmaster.ca/display/publication1628470\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem\", \"url\": \"https://experts.mcmaster.ca/display/publication1581308\", \"journal\": \"Value in Health\", \"year\": \"2018\", \"doi\": \"10.1016/j.jval.2018.04.1439\"}, {\"title\": \"The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1543698\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action\", \"url\": \"https://experts.mcmaster.ca/display/publication1543701\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1543702\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication1498586\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1979440\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1979441\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Estimating The Global Annual Bleed Rate In Haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1635883\", \"journal\": \"Haemophilia\", \"year\": \"2017\"}, {\"title\": \"Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE)\", \"url\": \"https://experts.mcmaster.ca/display/publication995651\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.5964.5964\"}, {\"title\": \"NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT\", \"url\": \"https://experts.mcmaster.ca/display/publication626825\", \"journal\": \"American Journal of Hematology\", \"year\": \"2016\"}, {\"title\": \"A risk based decision making framework - stakeholder consultation essential to appropriate minimization of blood safety risk\", \"url\": \"https://experts.mcmaster.ca/display/publication1383708\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Development of a questionnaire to identify hemophilia A patient and clinician discussion opportunities around prophylaxis treatment options\", \"url\": \"https://experts.mcmaster.ca/display/publication1635831\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results\", \"url\": \"https://experts.mcmaster.ca/display/publication995670\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible\", \"url\": \"https://experts.mcmaster.ca/display/publication995693\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2016\"}, {\"title\": \"The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility\", \"url\": \"https://experts.mcmaster.ca/display/publication995689\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Cultivating and Preparing Future Leaders\", \"url\": \"https://experts.mcmaster.ca/display/publication1635832\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Speaking as one voice: Uniting and educating advocates\", \"url\": \"https://experts.mcmaster.ca/display/publication1635834\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"The Rise of the Patient Voice\", \"url\": \"https://experts.mcmaster.ca/display/publication1635833\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Hemophilia and von Willebrand disease patients' perceptions of care at US Hemophilia Treatment Centers\", \"url\": \"https://experts.mcmaster.ca/display/publication1635887\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Morbidity and Mortality of Transthyretin (TTR) Amyloid Cardiomyopathy (ATTR-CM): Transthyretin Amyloidosis Cardiac Study (TRACS) a Prospective Evaluation\", \"url\": \"https://experts.mcmaster.ca/display/publication1635857\", \"journal\": \"Circulation\", \"year\": \"2008\"}, {\"title\": \"Global Forum of the World Federation of Hemophilia, September 26\\u201327, 2005, Montreal, Quebec, Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication1751584\", \"journal\": \"Transfusion and Apheresis Science\", \"year\": \"2006\", \"doi\": \"10.1016/j.transci.2006.07.003\"}], \"other\": [{\"title\": \"Geographical Gerontology\", \"url\": \"https://experts.mcmaster.ca/display/publication1728051\", \"year\": \"2017\", \"doi\": \"10.4324/9781315281216\"}, {\"title\": \"Preface\", \"url\": \"https://experts.mcmaster.ca/display/publication1751635\", \"year\": \"2015\", \"doi\": \"10.4324/9781315728209\"}], \"preprints\": [{\"title\": \"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3285816\", \"year\": \"2021\", \"doi\": \"10.2196/preprints.30797\"}]}",
  "teaching_activities_json": "[]",
  "teaching_courses_count": 0,
  "coauthor_network_url": "https://experts.mcmaster.ca/vis/author-network/skinnm5",
  "science_map_url": "https://experts.mcmaster.ca/vis/map-of-science/skinnm5",
  "profile_url": "https://experts.mcmaster.ca/individual/skinnm5",
  "scraped_date": "2025-07-27T15:13:38.722500",
  "csv_name": "Mark Skinner",
  "csv_degree": "JD",
  "csv_university": "McMaster University",
  "csv_faculty": "Faculty of Health Sciences",
  "csv_department": "Department of Health Research Methods, Evidence, and Impact (HEI)",
  "csv_other_depts": NaN,
  "csv_position": "Assistant Professor",
  "csv_full_time": true,
  "csv_faculty_type": "Faculty",
  "csv_adjunct": false,
  "csv_uni_email": "skinnm5@mcmaster.ca",
  "csv_other_email": NaN,
  "csv_website": NaN,
  "csv_misc": NaN,
  "csv_twitter": NaN,
  "csv_phone": NaN,
  "csv_fax": NaN,
  "csv_gscholar": NaN,
  "csv_scopus": NaN,
  "csv_wos": NaN,
  "csv_orcid": NaN,
  "csv_researchgate": NaN,
  "csv_academicedu": NaN,
  "csv_linkedin": NaN,
  "csv_mendely": NaN,
  "publications": {
    "journal_articles": [
      {
        "title": "Recommending defunct therapies is a safety risk for hemophilia.",
        "url": "https://experts.mcmaster.ca/display/publication3540487",
        "journal": "Blood Transfusion",
        "year": "2025",
        "doi": "10.2450/BloodTransfus.982"
      },
      {
        "title": "Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY Studies.",
        "url": "https://experts.mcmaster.ca/display/publication3505266",
        "journal": "Haemophilia",
        "year": "2025",
        "doi": "10.1111/hae.15134"
      },
      {
        "title": "Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease.",
        "url": "https://experts.mcmaster.ca/display/publication3494611",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15136"
      },
      {
        "title": "International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.",
        "url": "https://experts.mcmaster.ca/display/publication3494222",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15135"
      },
      {
        "title": "A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiative.",
        "url": "https://experts.mcmaster.ca/display/publication3492767",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15122"
      },
      {
        "title": "Development of the World Federation of Hemophilia Shared Decision-Making Tool.",
        "url": "https://experts.mcmaster.ca/display/publication3477986",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15100"
      },
      {
        "title": "Development of the coreHEM mental health patient-reported outcome measure - A novel mental health outlook measure for people with haemophilia.",
        "url": "https://experts.mcmaster.ca/display/publication3470094",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15085"
      },
      {
        "title": "Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List",
        "url": "https://experts.mcmaster.ca/display/publication3460416",
        "journal": "The Lancet Haematology",
        "year": "2024",
        "doi": "10.1016/s2352-3026(24)00223-0"
      },
      {
        "title": "Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry",
        "url": "https://experts.mcmaster.ca/display/publication3320502",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.14895"
      },
      {
        "title": "Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1",
        "url": "https://experts.mcmaster.ca/display/publication3290241",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.jtha.2023.08.032"
      },
      {
        "title": "Hemophilia gene therapy: first, do no harm",
        "url": "https://experts.mcmaster.ca/display/publication3259128",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.jtha.2023.06.016"
      },
      {
        "title": "Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science",
        "url": "https://experts.mcmaster.ca/display/publication2981108",
        "journal": "Expert Review of Hematology",
        "year": "2023",
        "doi": "10.1080/17474086.2023.2183836"
      },
      {
        "title": "Data sharing to advance gene‐targeted therapies in rare diseases",
        "url": "https://experts.mcmaster.ca/display/publication2658805",
        "journal": "American Journal of Medical Genetics - Seminars in Medical Genetics",
        "year": "2023",
        "doi": "10.1002/ajmg.c.32028"
      },
      {
        "title": "Gene‐targeted therapies: Towards equitable development, diagnosis, and access",
        "url": "https://experts.mcmaster.ca/display/publication2777362",
        "journal": "American Journal of Medical Genetics - Seminars in Medical Genetics",
        "year": "2023",
        "doi": "10.1002/ajmg.c.32032"
      },
      {
        "title": "Humanistic burden of problem joints for children and adults with haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2658804",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14731"
      },
      {
        "title": "Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature",
        "url": "https://experts.mcmaster.ca/display/publication2440132",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14676"
      },
      {
        "title": "Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B",
        "url": "https://experts.mcmaster.ca/display/publication2178281",
        "journal": "Journal of Medical Economics",
        "year": "2022",
        "doi": "10.1080/13696998.2022.2049552"
      },
      {
        "title": "Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years",
        "url": "https://experts.mcmaster.ca/display/publication2431417",
        "journal": "The Lancet Haematology",
        "year": "2022",
        "doi": "10.1016/s2352-3026(22)00209-5"
      },
      {
        "title": "User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study",
        "url": "https://experts.mcmaster.ca/display/publication2172480",
        "journal": "JMIR Human Factors",
        "year": "2022",
        "doi": "10.2196/30797"
      },
      {
        "title": "A preliminary application of a haemophilia value framework to emerging therapies in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2178284",
        "journal": "Haemophilia",
        "year": "2022",
        "doi": "10.1111/hae.14511"
      },
      {
        "title": "The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making",
        "url": "https://experts.mcmaster.ca/display/publication2274074",
        "journal": "Patient Preference and Adherence",
        "year": "2022",
        "doi": "10.2147/ppa.s355627"
      },
      {
        "title": "Eliminating Panglossian thinking in development of AAV therapeutics",
        "url": "https://experts.mcmaster.ca/display/publication2154110",
        "journal": "Molecular Therapy",
        "year": "2021",
        "doi": "10.1016/j.ymthe.2021.10.025"
      },
      {
        "title": "Evaluation of the sexual health in people living with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2129783",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14410"
      },
      {
        "title": "Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment",
        "url": "https://experts.mcmaster.ca/display/publication2049462",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14383"
      },
      {
        "title": "The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies",
        "url": "https://experts.mcmaster.ca/display/publication1987173",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14363"
      },
      {
        "title": "Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU",
        "url": "https://experts.mcmaster.ca/display/publication1967597",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14309"
      },
      {
        "title": "Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders",
        "url": "https://experts.mcmaster.ca/display/publication1960659",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14271"
      },
      {
        "title": "Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set",
        "url": "https://experts.mcmaster.ca/display/publication1963914",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1002/rth2.12488"
      },
      {
        "title": "Evidence of a disability paradox in patient‐reported outcomes in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1959641",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14278"
      },
      {
        "title": "Identified unmet needs and proposed solutions in mild‐to‐moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts",
        "url": "https://experts.mcmaster.ca/display/publication1958361",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14168"
      },
      {
        "title": "Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders",
        "url": "https://experts.mcmaster.ca/display/publication2142543",
        "journal": "Journal of Blood Medicine",
        "year": "2021",
        "doi": "10.2147/jbm.s325031"
      },
      {
        "title": "Non‐severe haemophilia: Is it benign? – Insights from the PROBE study",
        "url": "https://experts.mcmaster.ca/display/publication1923964",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14105"
      },
      {
        "title": "Personalising haemophilia management with shared decision making",
        "url": "https://experts.mcmaster.ca/display/publication3561871",
        "journal": "The Journal of Haemophilia Practice",
        "year": "2021",
        "doi": "10.17225/jhp00178"
      },
      {
        "title": "The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication3561872",
        "journal": "The Journal of Haemophilia Practice",
        "year": "2021",
        "doi": "10.17225/jhp00176"
      },
      {
        "title": "Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company",
        "url": "https://experts.mcmaster.ca/display/publication1936087",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14144"
      },
      {
        "title": "Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication1937783",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1111/jth.15023"
      },
      {
        "title": "Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?",
        "url": "https://experts.mcmaster.ca/display/publication1925854",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14131"
      },
      {
        "title": "The role of telemedicine in the delivery of health care in the COVID‐19 pandemic",
        "url": "https://experts.mcmaster.ca/display/publication1894317",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14044"
      },
      {
        "title": "The World Federation of Hemophilia Annual Global Survey 1999‐2018",
        "url": "https://experts.mcmaster.ca/display/publication1914356",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14012"
      },
      {
        "title": "World Federation of Hemophilia Gene Therapy Registry",
        "url": "https://experts.mcmaster.ca/display/publication1910847",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14015"
      },
      {
        "title": "Achieving the unimaginable: Health equity in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1679558",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.13862"
      },
      {
        "title": "An international survey to inform priorities for new guidelines on von Willebrand disease",
        "url": "https://experts.mcmaster.ca/display/publication1680493",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.13881"
      },
      {
        "title": "Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication1634148",
        "journal": "Haemophilia",
        "year": "2019",
        "doi": "10.1111/hae.13703"
      },
      {
        "title": "Hemophilia trials in the twenty‐first century: Defining patient important outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1639469",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1002/rth2.12195"
      },
      {
        "title": "The 1stWFHGene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world",
        "url": "https://experts.mcmaster.ca/display/publication1751434",
        "journal": "Haemophilia",
        "year": "2019",
        "doi": "10.1111/hae.13673"
      },
      {
        "title": "Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains",
        "url": "https://experts.mcmaster.ca/display/publication1612046",
        "journal": "Haemophilia",
        "year": "2019",
        "doi": "10.1111/hae.13649"
      },
      {
        "title": "The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1505309",
        "journal": "Pilot and Feasibility Studies",
        "year": "2018",
        "doi": "10.1186/s40814-018-0253-0"
      },
      {
        "title": "Aging Through the Lens of Historical Time, Space, and Place",
        "url": "https://experts.mcmaster.ca/display/publication1728103",
        "journal": "The Gerontologist",
        "year": "2018",
        "doi": "10.1093/geront/gny070"
      },
      {
        "title": "Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project",
        "url": "https://experts.mcmaster.ca/display/publication1534544",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13504"
      },
      {
        "title": "Genotypes, phenotypes and whole genome sequence: Approaches from theMy Life Our Futurehaemophilia project",
        "url": "https://experts.mcmaster.ca/display/publication1635782",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13506"
      },
      {
        "title": "Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies",
        "url": "https://experts.mcmaster.ca/display/publication1635783",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13313"
      },
      {
        "title": "Risk‐based decision making and ethical considerations in donor compensation for plasma‐derived medicinal products",
        "url": "https://experts.mcmaster.ca/display/publication1635794",
        "journal": "Transfusion",
        "year": "2016",
        "doi": "10.1111/trf.13764"
      },
      {
        "title": "Improving comprehensive care in the haemophilia community: building on theHEROStudy",
        "url": "https://experts.mcmaster.ca/display/publication1635784",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.12945"
      },
      {
        "title": "NHF‐McMaster Guideline on Care Models for Haemophilia Management",
        "url": "https://experts.mcmaster.ca/display/publication172779",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13008"
      },
      {
        "title": "Assessments of outcome in haemophilia – a patient perspective",
        "url": "https://experts.mcmaster.ca/display/publication1635785",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.12922"
      },
      {
        "title": "The national haemophilia program standards, evaluation and oversight systems in the United States of America.",
        "url": "https://experts.mcmaster.ca/display/publication1635797",
        "journal": "Blood Transfusion",
        "year": "2014",
        "doi": "10.2450/2014.0019-14s"
      },
      {
        "title": "World Federation of Hemophilia: 50 years of advancing treatment for all",
        "url": "https://experts.mcmaster.ca/display/publication1635786",
        "journal": "Haemophilia",
        "year": "2013",
        "doi": "10.1111/hae.12200"
      },
      {
        "title": "Factor VIII Products and Inhibitors in Severe Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication411185",
        "journal": "New England Journal of Medicine",
        "year": "2013",
        "doi": "10.1056/nejmc1301995"
      },
      {
        "title": "Factor VIII products and inhibitors in severe hemophilia A.",
        "url": "https://experts.mcmaster.ca/display/publication172957",
        "journal": "New England Journal of Medicine",
        "year": "2013",
        "doi": "10.1056/NEJMc1301995"
      },
      {
        "title": "Gene Therapy for Hemophilia: Addressing the Coming Challenges of Affordability and Accessibility",
        "url": "https://experts.mcmaster.ca/display/publication1635787",
        "journal": "Molecular Therapy",
        "year": "2013",
        "doi": "10.1038/mt.2012.272"
      },
      {
        "title": "Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)",
        "url": "https://experts.mcmaster.ca/display/publication1635888",
        "journal": "American Heart Journal",
        "year": "2012",
        "doi": "10.1016/j.ahj.2012.04.015"
      },
      {
        "title": "Haemophilia care – past, present and future from a patient perspective",
        "url": "https://experts.mcmaster.ca/display/publication1635788",
        "journal": "Haemophilia",
        "year": "2012",
        "doi": "10.1111/j.1365-2516.2012.02892.x"
      },
      {
        "title": "WFH: Closing the global gap – achieving optimal care",
        "url": "https://experts.mcmaster.ca/display/publication1635802",
        "journal": "Haemophilia",
        "year": "2012",
        "doi": "10.1111/j.1365-2516.2012.02822.x"
      },
      {
        "title": "Ensuring maximum outcomes and benefits in comprehensive care for bleeding disorders through surveillance and data collection",
        "url": "https://experts.mcmaster.ca/display/publication1635807",
        "journal": "Hematology",
        "year": "2012",
        "doi": "10.1179/102453312x13336169156573"
      },
      {
        "title": "Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1751606",
        "journal": "Molecular Therapy",
        "year": "2011",
        "doi": "10.1038/mt.2011.203"
      },
      {
        "title": "Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements",
        "url": "https://experts.mcmaster.ca/display/publication1635789",
        "journal": "British Journal of Haematology",
        "year": "2011",
        "doi": "10.1111/j.1365-2141.2011.08765.x"
      },
      {
        "title": "Building our global family – achieving treatment for all",
        "url": "https://experts.mcmaster.ca/display/publication1635790",
        "journal": "Haemophilia",
        "year": "2010",
        "doi": "10.1111/j.1365-2516.2010.02285.x"
      },
      {
        "title": "Global data and haemophilia care trends: commentary",
        "url": "https://experts.mcmaster.ca/display/publication1635806",
        "journal": "Haemophilia",
        "year": "2010",
        "doi": "10.1111/j.1365-2516.2009.02177.x"
      },
      {
        "title": "WFH – the cornerstone of global development: 45 years of progress",
        "url": "https://experts.mcmaster.ca/display/publication1635791",
        "journal": "Haemophilia",
        "year": "2008",
        "doi": "10.1111/j.1365-2516.2008.01707.x"
      },
      {
        "title": "Treatment for all: a vision for the future",
        "url": "https://experts.mcmaster.ca/display/publication1635792",
        "journal": "Haemophilia",
        "year": "2006",
        "doi": "10.1111/j.1365-2516.2006.01280.x"
      },
      {
        "title": "More on: are randomized clinical trials the only truth? Not always",
        "url": "https://experts.mcmaster.ca/display/publication1635830",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2006",
        "doi": "10.1111/j.1538-7836.2006.01938.x"
      },
      {
        "title": "What is a cure and how do we get there?",
        "url": "https://experts.mcmaster.ca/display/publication1635824",
        "journal": "Haemophilia",
        "year": "2004",
        "doi": "10.1111/j.1365-2516.2004.00999.x"
      }
    ],
    "chapters": [
      {
        "title": "Geographical gerontology: Progress and possibilities",
        "url": "https://experts.mcmaster.ca/display/publication1728053",
        "year": "2017",
        "doi": "10.4324/9781315281216"
      },
      {
        "title": "Space and place in geographical gerontology: Theoretical traditions, formations of hope",
        "url": "https://experts.mcmaster.ca/display/publication1728054",
        "year": "2017",
        "doi": "10.4324/9781315281216"
      },
      {
        "title": "Ageing Resource Communities",
        "url": "https://experts.mcmaster.ca/display/publication1751634",
        "year": "2015",
        "doi": "10.4324/9781315728209"
      },
      {
        "title": "Perspectives on rural voluntarism",
        "url": "https://experts.mcmaster.ca/display/publication1751640",
        "year": "2015",
        "doi": "10.4324/9781315728209"
      },
      {
        "title": "Aging and Older People, Geography of",
        "url": "https://experts.mcmaster.ca/display/publication1728052",
        "year": "2015",
        "doi": "10.1016/b978-0-08-097086-8.72115-5"
      },
      {
        "title": "Comprehensive care and delivery of care: the global perspective",
        "url": "https://experts.mcmaster.ca/display/publication3261927",
        "year": "2014"
      }
    ],
    "conferences": [
      {
        "title": "Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication995654",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.14969"
      },
      {
        "title": "Initial results of the impact of valoctocogene roxaparvovec on pain occurrence and interference: Insights from PROBE",
        "url": "https://experts.mcmaster.ca/display/publication3277051",
        "journal": "Haemophilia",
        "year": "2023"
      },
      {
        "title": "A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA",
        "url": "https://experts.mcmaster.ca/display/publication2980744",
        "journal": "American Journal of Hematology",
        "year": "2023"
      },
      {
        "title": "COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK",
        "url": "https://experts.mcmaster.ca/display/publication2981099",
        "journal": "American Journal of Hematology",
        "year": "2023"
      },
      {
        "title": "NATIONAL ECONOMIC BURDEN OF ADULTS WITH SEVERE HEMOPHILIA A MANAGED WITH PROPHYLAXIS IN THE UNITED STATES",
        "url": "https://experts.mcmaster.ca/display/publication2981098",
        "journal": "American Journal of Hematology",
        "year": "2023"
      },
      {
        "title": "A Novel Methodology for Building Longitudinal, PatientCentric Real World Datasets in Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication2429824",
        "journal": "Blood",
        "year": "2021",
        "doi": "10.1182/blood-2021-146160Get"
      },
      {
        "title": "Relationship of EQ-5D Pain Domain and Bleeds - Insights from the PROBE Study",
        "url": "https://experts.mcmaster.ca/display/publication2122576",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY",
        "url": "https://experts.mcmaster.ca/display/publication1962004",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "Examination and Validation of a Patient-Centric Joint Metric: \"Problem Joint\"; Empirical Evidence from the CHESS US Dataset",
        "url": "https://experts.mcmaster.ca/display/publication1979439",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood-2020-140950"
      },
      {
        "title": "Developing a patient reported outcome measure to explore mental health outlook in people with Hemophilia: Development of a conceptual framework",
        "url": "https://experts.mcmaster.ca/display/publication1915794",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Education in people with Hemophilia - Insights from the PROBE Study",
        "url": "https://experts.mcmaster.ca/display/publication1914746",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Impact of Pain on Physical Activity by Persons with Hemophilia (PwH) from the HemACTIVE Patient Survey",
        "url": "https://experts.mcmaster.ca/display/publication1915792",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "International Standard Set of Health Outcomes that matter for people living with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1914745",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Quantifying the disability paradox in hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1915791",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Treatment adherence in people with hemophilia (PwH) who are restricted by pain: Findings from the HemACTIVE Patient Survey",
        "url": "https://experts.mcmaster.ca/display/publication1915793",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY",
        "url": "https://experts.mcmaster.ca/display/publication1692273",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1639464",
        "journal": "Molecular Therapy",
        "year": "2019"
      },
      {
        "title": "\"Problem Joint\" a more patient relevant definition for joint morbidity in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1628471",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Impact of acute and chronic pain on the EQ-5D: Insights from the PROBE study",
        "url": "https://experts.mcmaster.ca/display/publication1628468",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study",
        "url": "https://experts.mcmaster.ca/display/publication1628469",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Physical activity in persons with hemophilia (PwH) from France (FR), Italy (ITA), and United States (US) from the hemactive patient survey",
        "url": "https://experts.mcmaster.ca/display/publication1628467",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort",
        "url": "https://experts.mcmaster.ca/display/publication1628470",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem",
        "url": "https://experts.mcmaster.ca/display/publication1581308",
        "journal": "Value in Health",
        "year": "2018",
        "doi": "10.1016/j.jval.2018.04.1439"
      },
      {
        "title": "The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1543698",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action",
        "url": "https://experts.mcmaster.ca/display/publication1543701",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1543702",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication1498586",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study",
        "url": "https://experts.mcmaster.ca/display/publication1979440",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study",
        "url": "https://experts.mcmaster.ca/display/publication1979441",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Estimating The Global Annual Bleed Rate In Haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1635883",
        "journal": "Haemophilia",
        "year": "2017"
      },
      {
        "title": "Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE)",
        "url": "https://experts.mcmaster.ca/display/publication995651",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.5964.5964"
      },
      {
        "title": "NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT",
        "url": "https://experts.mcmaster.ca/display/publication626825",
        "journal": "American Journal of Hematology",
        "year": "2016"
      },
      {
        "title": "A risk based decision making framework - stakeholder consultation essential to appropriate minimization of blood safety risk",
        "url": "https://experts.mcmaster.ca/display/publication1383708",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Development of a questionnaire to identify hemophilia A patient and clinician discussion opportunities around prophylaxis treatment options",
        "url": "https://experts.mcmaster.ca/display/publication1635831",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results",
        "url": "https://experts.mcmaster.ca/display/publication995670",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible",
        "url": "https://experts.mcmaster.ca/display/publication995693",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2016"
      },
      {
        "title": "The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility",
        "url": "https://experts.mcmaster.ca/display/publication995689",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Cultivating and Preparing Future Leaders",
        "url": "https://experts.mcmaster.ca/display/publication1635832",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Speaking as one voice: Uniting and educating advocates",
        "url": "https://experts.mcmaster.ca/display/publication1635834",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "The Rise of the Patient Voice",
        "url": "https://experts.mcmaster.ca/display/publication1635833",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Hemophilia and von Willebrand disease patients' perceptions of care at US Hemophilia Treatment Centers",
        "url": "https://experts.mcmaster.ca/display/publication1635887",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Morbidity and Mortality of Transthyretin (TTR) Amyloid Cardiomyopathy (ATTR-CM): Transthyretin Amyloidosis Cardiac Study (TRACS) a Prospective Evaluation",
        "url": "https://experts.mcmaster.ca/display/publication1635857",
        "journal": "Circulation",
        "year": "2008"
      },
      {
        "title": "Global Forum of the World Federation of Hemophilia, September 26–27, 2005, Montreal, Quebec, Canada",
        "url": "https://experts.mcmaster.ca/display/publication1751584",
        "journal": "Transfusion and Apheresis Science",
        "year": "2006",
        "doi": "10.1016/j.transci.2006.07.003"
      }
    ],
    "other": [
      {
        "title": "Geographical Gerontology",
        "url": "https://experts.mcmaster.ca/display/publication1728051",
        "year": "2017",
        "doi": "10.4324/9781315281216"
      },
      {
        "title": "Preface",
        "url": "https://experts.mcmaster.ca/display/publication1751635",
        "year": "2015",
        "doi": "10.4324/9781315728209"
      }
    ],
    "preprints": [
      {
        "title": "User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3285816",
        "year": "2021",
        "doi": "10.2196/preprints.30797"
      }
    ]
  },
  "filename": "Mark_Skinner.json",
  "file_created": "2025-07-27T15:13:38.723045"
}